Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms

Gonzalez-Lopez, E., Escobar-Lopez, L., Obici, L., Saturi, G., Bezard, M., Saith, S. E., AbouEzzeddine, O. F., Mussinelli, R., Gagliardi, C., Kharoubi, M., Griffin, J. M., Dispenzieri, A., Vilches, S., Perlini, S., Longhi, S., Oghina, S., Rivas, A., Grogan, M., Maurer, M. S., … Garcia-Pavia, P. (2022). Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms. JACC: CardioOncology, 4(4), 442–454. https://doi.org/10.1016/j.jaccao.2022.07.007
Authors:
Esther González-López
Luis Escobar-López
Laura Obici
Giulia Saturi
Mélanie Bezard
Sunil E. Saith
Omar F. AbouEzzeddine
Roberta Mussinelli
Christian Gagliardi
Mounira Kharoubi
Jan M. Griffin
Angela Dispenzieri
Silvia Vilches
Stefano Perlini
Simone Longhi
Silvia Oghina
Adrian Rivas
Martha Grogan
Mathew S. Maurer
Thibaud Damy
Giovanni Palladini
Claudio Rapezzi
Pablo García‐Pavía
Affiliated Authors:
Sunil E. Saith
Jan M. Griffin
Mathew S. Maurer
Columbia Affiliation:
Subjects:
Molecular Mechanisms of Amyloidosis (OpenAlex Topic)
Mineral Metabolism in Chronic Kidney Disease (OpenAlex Topic)
Hypereosinophilic Syndrome and Related Disorders (OpenAlex Topic)
Author Keywords:
cardiac amyloidosis
early stages
heart failure
stabilizers
transthyretin
af, atrial fibrillation
attr-cm, transthyretin amyloid cardiomyopathy
attr-v, variant transthyretin amyloidosis
attr-wt, wild-type transthyretin amyloidosis
cv, cardiovascular
hf, heart failure
nac, national amyloid center
nt-probnp, n-terminal pro–brain natriuretic peptide
nyha, new york heart association
shr, subdistribution hr
ttr, transthyretin
egfr, estimated glomerular filtration rate
elink
Publication Type:
Article
Unique ID:
10.1016/j.jaccao.2022.07.007
PMID:
36444226
DOI:
10.1016/j.jaccao.2022.07.007
Journal:
JACC: CardioOncology
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: